'Vl monitoring' diaporamas de présentation

ART-A Development of an A ffordable R esistance T est for A frica

370 views • 27 slides

Background (1)

Changing Patterns of NRTI and PI Resistance Mutations Between 2006 and 2011 in ART experienced SA patients. Gert van Zyl 1 , Mathilda Claassen 1 , Susan Engelbrecht, 2 Tulio De Oliveira 2 , Wolfgang Preiser 3 , Natasha Wood 4 , Simon Travers 4 , Robert Shafer 5.

299 views • 23 slides

CD4 and VL Monitoring: Research and Development needs and Policy implications

CD4 and VL Monitoring: Research and Development needs and Policy implications. Monitoring ART session XVIII IAC Vienna 2010 Prof Charles Gilks UNAIDS India. CD4 and VL Monitoring: Research and Development needs and Policy implications. Core concepts Review of evidence

262 views • 16 slides

Jean-Claude Karasi M.D

Assessing the WHO- recommended First-line ART regimens for Resource- limited settings: comparison of the relative virologic efficacy and resistance patterns of TDF/3TC/NVP to AZT/3TC/NVP in a Rwandan Cohort. Jean-Claude Karasi M.D. Cohort description.

281 views • 7 slides